Skip to main content

BAKER BROS. ADVISORS LP

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1263508 NEW YORK, NY

Position in ACAD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$954,880,319
-$190,890,270 QoQ
Shares Held
42,896,690
0.0% QoQ
Ownership
25.1%
of shares outstanding
% of Portfolio
5.51%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BAKER BROS. ADVISORS LP holds $16,600,149,582 across 76 Biotechnology names. ACAD ranks #5 (5.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 ACAD
Acadia Pharmaceuticals Inc
This page
42,896,690 $954,880,319

All Filings in ACAD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $954,880,319 42,896,690
2026-02-24 $1,061,084,417 43,151,054
2025-12-31 $1,145,770,589 42,896,690
2025-09-30 $915,415,364 42,896,690
2025-06-30 $925,281,603 42,896,690
2025-03-31 $712,202,184 42,877,916
2024-12-31 $786,809,758 42,877,916
2024-09-30 $659,462,348 42,877,916
2024-06-30 $696,766,135 42,877,916
2024-03-31 $792,566,675 42,864,612
2023-12-31 $1,342,091,001 42,864,612
2023-09-30 $893,298,514 42,864,612
2023-06-30 $1,026,607,457 42,864,612
2023-03-31 $789,282,306 41,938,486
2022-12-31 $667,421,897 41,923,486
2022-09-30 $685,868,230 41,923,486
2022-06-30 $590,701,917 41,923,486
2022-03-31 $1,015,077,250 41,910,704
2021-12-31 $978,195,831 41,910,704
2021-09-30 $696,136,793 41,910,704
2021-06-30 $1,022,202,070 41,910,704
2021-03-31 $1,081,296,163 41,910,704
2020-12-31 $2,240,219,167 41,904,586
2020-09-30 $1,728,564,172 41,904,586
2020-06-30 $2,031,115,283 41,904,586
2020-03-31 $1,770,468,758 41,904,586